[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Pages 1558-1559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00355]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-43-2022]


Foreign-Trade Zone (FTZ) 27--Boston, Massachusetts; Authorization 
of Production Activity, Wyeth Pharmaceuticals, LLC (Shingles and Flu 
Vaccines), Andover, Massachusetts

    On September 8, 2022, Wyeth Pharmaceuticals, LLC (Wyeth) submitted 
a notification of proposed production activity to the FTZ Board for its 
facility within Subzone 27R, in Andover, Massachusetts.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (87 FR 56928, September 16, 2022). On 
January 6, 2023, the applicant was notified of the

[[Page 1559]]

FTZ Board's decision that no further review of the activity is 
warranted at this time. The production activity described in the 
notification was authorized, subject to the FTZ Act and the FTZ Board's 
regulations, including Section 400.14.

    Dated: January 6, 2023.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2023-00355 Filed 1-10-23; 8:45 am]
BILLING CODE 3510-DS-P